ELREXFIO

ELRANATAMAB-BCMM · U.S. Pharmaceuticals

Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for ELREXFIO, covering 2023-08-14 to 2026-03-25. Get the full timeline:

Most recent: FDA Approved: ELREXFIO — Supplemental Application (U.S. Pharmaceuticals)